======= TBX18 ======= == Gene Information == * **Official Symbol**: TBX18 * **Official Name**: T-box transcription factor 18 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9096|9096]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95935|O95935]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBX18&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX18|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604613|Open OMIM]] == Function Summary == * **Entrez Summary**: This genes codes for a member of an evolutionarily conserved family of transcription factors that plays a crucial role in embryonic development. The family is characterized by the presence of the DNA-binding T-box domain and is divided into five sub-families based on sequence conservation in this domain. The encoded protein belongs to the vertebrate specific Tbx1 sub-family. The protein acts as a transcriptional repressor by antagonizing transcriptional activators in the T-box family. The protein forms homo- or heterodimers with other transcription factors of the T-box family or other transcription factors. [provided by RefSeq, Nov 2012]. * **UniProt Summary**: Acts as transcriptional repressor involved in developmental processes of a variety of tissues and organs, including the heart and coronary vessels, the ureter and the vertebral column. Required for embryonic development of the sino atrial node (SAN) head area. {ECO:0000250|UniProtKB:Q9EPZ6, ECO:0000269|PubMed:26235987}. |T-box| |regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation| |negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation| |Tle3-Aes complex| |RNA polymerase II activating transcription factor binding| |somitogenesis| |transcription regulatory region sequence-specific DNA binding| |somite development| |cell fate specification| |segmentation| |regulation of embryonic development| |morphogenesis of embryonic epithelium| |negative regulation of canonical Wnt signaling pathway| |negative regulation of Wnt signaling pathway| |anterior/posterior pattern specification| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |cell fate commitment| |regulation of canonical Wnt signaling pathway| |renal system development| |RNA polymerase II regulatory region sequence-specific DNA binding| |urogenital system development| |regionalization| |regulation of Wnt signaling pathway| |morphogenesis of an epithelium| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |protein heterodimerization activity| |tissue morphogenesis| |embryonic morphogenesis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |anatomical structure formation involved in morphogenesis| |negative regulation of developmental process| |embryo development| |regulation of anatomical structure morphogenesis| |epithelium development| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15014 * **Expression level (log2 read counts)**: -2.17 {{:chemogenomics:nalm6 dist.png?nolink |}}